Dr. Armand Keating, MD, FRCP(C), Director, Cell Therapy Program and Philip S. Orsino Facility for Cell Therapy, Princess Margaret Hospital/Ontario Cancer Institute, introduces the 58th ASH Annual Meeting Press Briefing in San Diego, CA. Research to be presented introduces new therapies and methods, concluding that gene therapy and emerging drug delivery methods hold promise for patients with various forms of blood diseases.
Press Briefing Introduction: Developing Novel Therapies and Unique Delivery Methods to Improve Treatment for Bleeding Crises
